Search
Denali Therapeutics Inc
DNLIAdd to Watchlist
24.040USD
+0.470+1.99%
Close 07-28 16:00（ET）Quotes delayed by 15 min
3.81BMarket Cap
LossP/E TTM
Denali Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-27The current valuation score of Denali Therapeutics Inc is 7.53, ranking 214 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.18, which is -47.42% below the recent high of -4.30 and -251.37% above the recent low of -28.75.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.